Global healthcare is gradually transforming itself as it looks towards regenerative medicine and stem cell therapies. Especially, as it confronts increasingly costly treatments that are palliative in nature, rather than symptomatic; and the Asia Pacific (APAC) looks set to be a major contributor to that growth.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
